Terms: = Skin cancer AND Neurokinin
13 results:
1. Antinociceptive and Cytotoxic Activity of Opioid Peptides with Hydrazone and Hydrazide Moieties at the C-Terminus.
Dyniewicz J; Lipiński PFJ; Kosson P; Bochyńska-Czyż M; Matalińska J; Misicka A
Molecules; 2020 Jul; 25(15):. PubMed ID: 32731576
[TBL] [Abstract] [Full Text] [Related]
2. neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.
Vincenzi B; Trower M; Duggal A; Guglielmini P; Harris P; Jackson D; Lacouture ME; Ratti E; Tonini G; Wood A; Ständer S
BMJ Open; 2020 Feb; 10(2):e030114. PubMed ID: 32034016
[TBL] [Abstract] [Full Text] [Related]
3. Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial.
Zic JA; Straka BT; McGirt LY; Nian H; Yu C; Brown NJ
JAMA Dermatol; 2018 Oct; 154(10):1221-1222. PubMed ID: 30140912
[TBL] [Abstract] [Full Text] [Related]
4. Supportive Treatments for Patients with cancer.
Jordan K; Feyer P; Höller U; Link H; Wörmann B; Jahn F
Dtsch Arztebl Int; 2017 Jul; 114(27-28):481-487. PubMed ID: 28764837
[TBL] [Abstract] [Full Text] [Related]
5. Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.
Takeuchi H; Saeki T; Aiba K; Tamura K; Aogi K; Eguchi K; Okita K; Kagami Y; Tanaka R; Nakagawa K; Fujii H; Boku N; Wada M; Akechi T; Udagawa Y; Okawa Y; Onozawa Y; Sasaki H; Shima Y; Shimoyama N; Takeda M; Nishidate T; Yamamoto A; Ikeda T; Hirata K
Int J Clin Oncol; 2016 Feb; 21(1):1-12. PubMed ID: 26081252
[TBL] [Abstract] [Full Text] [Related]
6. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
[TBL] [Abstract] [Full Text] [Related]
7. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
[TBL] [Abstract] [Full Text] [Related]
8. NK-1 as a melanoma target.
Muñoz M; Bernabeu-Wittel J; Coveñas R
Expert Opin Ther Targets; 2011 Jul; 15(7):889-97. PubMed ID: 21592000
[TBL] [Abstract] [Full Text] [Related]
9. The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines.
Muñoz M; Rosso M; Robles-Frias MJ; Salinas-Martín MV; Rosso R; González-Ortega A; Coveñas R
Lab Invest; 2010 Aug; 90(8):1259-69. PubMed ID: 20458280
[TBL] [Abstract] [Full Text] [Related]
10. Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts.
Liu JY; Hu JH; Zhu QG; Li FQ; Wang J; Sun HJ
Int Immunopharmacol; 2007 Jun; 7(6):816-23. PubMed ID: 17466915
[TBL] [Abstract] [Full Text] [Related]
11. Antitumoral action of the neurokinin-1 receptor antagonist L-733 060 on human melanoma cell lines.
Muñoz M; Pérez A; Rosso M; Zamarriego C; Rosso R
Melanoma Res; 2004 Jun; 14(3):183-8. PubMed ID: 15179186
[TBL] [Abstract] [Full Text] [Related]
12. Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology.
Mellentin-Michelotti J; Evangelista LT; Swartzman EE; Miraglia SJ; Werner WE; Yuan PM
Anal Biochem; 1999 Aug; 272(2):182-90. PubMed ID: 10415087
[TBL] [Abstract] [Full Text] [Related]
13. Plasma concentrations and urinary excretion of regulatory peptides in patients with urticaria pigmentosa.
Nordlind K; Theodorsson E
Ups J Med Sci; 1993; 98(2):169-78. PubMed ID: 8184517
[TBL] [Abstract] [Full Text] [Related]
